PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.\', \'Center for Medicine and the Microbiome and.\', \'Acute Lung Injury Center of Excellence, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.\', \'Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Florida, Weston Hospital, Weston, Florida, USA.\', \'School of Medicine, Tsinghua University, Beijing, China.\', \'Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.\', \'Associates of Cape Cod Inc., East Falmouth, Massachusetts, USA.\', \'Department of Infectious Diseases and Microbiology and.\', \'Departments of Physical Medicine and Rehabilitation, Neuroscience, and Clinical and Translational Science, Center for Neuroscience, Safar Center for Resuscitation Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.\', \'Department of Emergency and Critical Care Medicine, First Affiliated Hospital of Chongqing Medical University, Chongqing, China.\', \'Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.\', \'Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1172/jci.insight.141277141277
?:hasPublicationType
?:journal
  • JCI insight
is ?:pmid of
?:pmid
?:pmid
  • 34128840
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Plasma 1,3-β-d-glucan levels predict adverse clinical outcomes in critical illness.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all